Management of Ocular Diseases Using Lutein and Zeaxanthin: What Have We Learned from Experimental Animal Studies?

Zeaxanthin and lutein are two carotenoid pigments that concentrated in the retina, especially in the macula. The effects of lutein and zeaxanthin on the prevention and treatment of various eye diseases, including age-related macular degeneration, diabetic retinopathy and cataract, ischemic/hypoxia i...

Full description

Saved in:
Bibliographic Details
Main Authors: Chunyan Xue, Richard Rosen, Adrienne Jordan, Dan-Ning Hu
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2015/523027
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832555845072715776
author Chunyan Xue
Richard Rosen
Adrienne Jordan
Dan-Ning Hu
author_facet Chunyan Xue
Richard Rosen
Adrienne Jordan
Dan-Ning Hu
author_sort Chunyan Xue
collection DOAJ
description Zeaxanthin and lutein are two carotenoid pigments that concentrated in the retina, especially in the macula. The effects of lutein and zeaxanthin on the prevention and treatment of various eye diseases, including age-related macular degeneration, diabetic retinopathy and cataract, ischemic/hypoxia induced retinopathy, light damage of the retina, retinitis pigmentosa, retinal detachment, and uveitis, have been studied in different experimental animal models. In these animal models, lutein and zeaxanthin have been reported to have beneficial effects in protecting ocular tissues and cells (especially the retinal neurons) against damage caused by different etiological factors. The mechanisms responsible for these effects of lutein and zeaxanthin include prevention of phototoxic damage by absorption of blue light, reduction of oxidative stress through antioxidant activity and free radical scavenging, and their anti-inflammatory and antiangiogenic properties. The results of these experimental animal studies may provide new preventive and therapeutic procedures for clinical management of various vision-threatening diseases.
format Article
id doaj-art-17f93a9c5b3f45c7a53a9d2f918f256c
institution Kabale University
issn 2090-004X
2090-0058
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-17f93a9c5b3f45c7a53a9d2f918f256c2025-02-03T05:46:57ZengWileyJournal of Ophthalmology2090-004X2090-00582015-01-01201510.1155/2015/523027523027Management of Ocular Diseases Using Lutein and Zeaxanthin: What Have We Learned from Experimental Animal Studies?Chunyan Xue0Richard Rosen1Adrienne Jordan2Dan-Ning Hu3Department of Ophthalmology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu 210002, ChinaDepartment of Ophthalmology, The New York Eye and Ear Infirmary of Mount Sinai, Ichan School of Medicine at Mount Sinai, New York, NY 10003, USADepartment of Pathology, The New York Eye and Ear Infirmary of Mount Sinai, Ichan School of Medicine at Mount Sinai, New York, NY 10003, USADepartment of Ophthalmology, The New York Eye and Ear Infirmary of Mount Sinai, Ichan School of Medicine at Mount Sinai, New York, NY 10003, USAZeaxanthin and lutein are two carotenoid pigments that concentrated in the retina, especially in the macula. The effects of lutein and zeaxanthin on the prevention and treatment of various eye diseases, including age-related macular degeneration, diabetic retinopathy and cataract, ischemic/hypoxia induced retinopathy, light damage of the retina, retinitis pigmentosa, retinal detachment, and uveitis, have been studied in different experimental animal models. In these animal models, lutein and zeaxanthin have been reported to have beneficial effects in protecting ocular tissues and cells (especially the retinal neurons) against damage caused by different etiological factors. The mechanisms responsible for these effects of lutein and zeaxanthin include prevention of phototoxic damage by absorption of blue light, reduction of oxidative stress through antioxidant activity and free radical scavenging, and their anti-inflammatory and antiangiogenic properties. The results of these experimental animal studies may provide new preventive and therapeutic procedures for clinical management of various vision-threatening diseases.http://dx.doi.org/10.1155/2015/523027
spellingShingle Chunyan Xue
Richard Rosen
Adrienne Jordan
Dan-Ning Hu
Management of Ocular Diseases Using Lutein and Zeaxanthin: What Have We Learned from Experimental Animal Studies?
Journal of Ophthalmology
title Management of Ocular Diseases Using Lutein and Zeaxanthin: What Have We Learned from Experimental Animal Studies?
title_full Management of Ocular Diseases Using Lutein and Zeaxanthin: What Have We Learned from Experimental Animal Studies?
title_fullStr Management of Ocular Diseases Using Lutein and Zeaxanthin: What Have We Learned from Experimental Animal Studies?
title_full_unstemmed Management of Ocular Diseases Using Lutein and Zeaxanthin: What Have We Learned from Experimental Animal Studies?
title_short Management of Ocular Diseases Using Lutein and Zeaxanthin: What Have We Learned from Experimental Animal Studies?
title_sort management of ocular diseases using lutein and zeaxanthin what have we learned from experimental animal studies
url http://dx.doi.org/10.1155/2015/523027
work_keys_str_mv AT chunyanxue managementofoculardiseasesusingluteinandzeaxanthinwhathavewelearnedfromexperimentalanimalstudies
AT richardrosen managementofoculardiseasesusingluteinandzeaxanthinwhathavewelearnedfromexperimentalanimalstudies
AT adriennejordan managementofoculardiseasesusingluteinandzeaxanthinwhathavewelearnedfromexperimentalanimalstudies
AT danninghu managementofoculardiseasesusingluteinandzeaxanthinwhathavewelearnedfromexperimentalanimalstudies